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1. Introduction 
Clinicians are traditionally taught that the differential diagnosis of microcytic anemia is 
limited to a very few causes, with iron deficiency anemia on top of that list. While this may 
be true, the specific etiology of these causes and specifically the exact cause of the iron 
deficiency in each case is of clinical importance, as treatment of the anemia is very different 
for each cause. Just as the most common reason for severe microcytic anemia at any age is 
iron deficiency, the most common reasons for that deficiency at any age involve the 
gastrointestinal tract. The gastrointestinal tract is both the site of iron uptake and the most 
common site of blood loss. Thus, the gastrointestinal specialist plays a key role in 
diagnosing and managing microcytic anemia and must understand the various etiologies of 
microcytic anemia that are likely or possible in the population seen, including those cases 
that do not have a GI cause. In this chapter we will explain in a case based format the proper 
workup of the child and adolescent with microcytic anemia, emphasizing the role of the GI 
tract in the mechanism and of the GI specialist in the diagnosis and management. 
2. Overview of anemia 
Anemia refers to a hemoglobin (Hgb) or hematocrit (Hct) level lower than adult range or the 
age-adjusted range for healthy children. Normal values also vary depending on the gender 
and race of the patient. Since the main physiological role of red blood cells (RBCs) is to 
deliver oxygen to tissues, anemia is a condition where the body’s metabolic demands for 
oxygen may not be adequately achieved. The condition is usually secondary to various 
pathologic processes and is not considered a disease in itself.  
The causes for anemia can be broadly categorized into three pathological processes: 
decreased or ineffective erythropoiesis, increased hemolysis, and blood loss. However, cases 
where anemia is multifatorial in origin can exist. Anemia can also be further classified as 
microcytic, normocytic or macrocytic, referring to the mean corpuscular volume (MCV) 
which measures RBCs size, ranging from small, normal and large, respectively. This chapter 
will focus on microcytic anemia in children. The cases and information given are applicable 
to the general practitioner, but are aimed specifically at the pediatric gastroenterologist, 
focusing specifically on severe anemias that are severely microcytic, because these are the 
cases that impact the gastroenterologist most. An effort will be made to clarify much of the 
commonly thought but vague and misleading information about this condition.  
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There have been numerous reviews on the evaluation of anemia and microcytic anemia in 
children (Jain & Kamat 2009, Janus & Moerschel 2010). Although these reviews attempt to be 
comprehensive, they tend to be overly simplistic and misleading. Specifically with regard to 
microcytic anemia, the impression given is that nutritional deficiency is the most frequent 
cause of iron deficiency and hence microcytic anemia. Although this may be true for mild 
anemia, it is certainly not true for severe anemia, where blood loss is far more common. 
While a child with a hemoglobin of 11 g/dL and mild microcytosis may have a lack of 
sufficient iron in his or her diet, a hemoglobin of 5 g/dL and MCV of 55 fL cannot be due to 
nutrition alone. Anyone at any age with such values requires investigation for a serious 
condition and should not be treated with iron supplementation alone. To assume that most 
cases of microcytosis should be treated with supplemental iron alone is to miss the 
opportunity and the necessity of the proper workup for significant pathology. 
2.1 Epidemiology of iron deficiency in children 
Iron deficiency and iron deficiency anemia affect a large proportion of people worldwide 
(Beard & Stoltzfus, 2001; Benoit 2001; Stoltzfus, 2001). According to the Fourth National 
Health and Nutrition Examination Survey (NHANES IV), iron deficiency without anemia 
exists in 7% of toddlers aged 1 to 2 years, 9% of adolescent girls, and 16% of women of 
childbearing age, (Looker, 2002) a true public health concern. Unfortunately, studies of the 
prevalence of iron deficiency anemia use arbitrary definitions of anemia and iron deficiency, 
such as a hemoglobin less than 11 (Eden & Mir, 1997). There is often no attempt to separate 
iron deficiency based on severity, so that the true incidence of severe iron deficiency anemia 
is unknown. 
It must be remembered that iron deficiency and iron deficiency anemia are somewhat 
distinct, but overlapping and related disorders. Although confirmatory studies are lacking, 
it is probably true that the greatest cause of iron deficiency worldwide and in the United 
States is nutrition, i.e. lack of sufficient iron in the diet, and the greatest cause of iron 
deficiency anemia worldwide and in the United States is slow gastrointestinal bleeding. 
Statistics stating the leading causes of these conditions can easily mislead the practitioner, 
since the epidemiology of iron deficiency and iron deficiency are different, and also varies 
by age, gender, socioeconomic status and geography. Worldwide, and especially in poor 
countries, infestation by hookworm (mostly Necator americanus and Ancylostoma 
duodenale) is the leading cause of gastrointestinal blood loss leading to iron deficiency and 
iron deficiency anemia. Infestation by Trichuris trichiura, the cause of trichuriasis 
(whipworm) infection is common throughout many parts of the world, and symptomatic 
infestations leading to iron deficiency or growth retardation preferentially affect children 
between 2 and 10 years of age. By contrast, in the United States, parasitic infestation has 
become distinctly rare due to improved sanitation and the fact that most children in the U.S. 
now wear shoes when outdoors. In the United States, cultural differences in feeding 
practices affect the incidence of iron deficiency anemia (Kwiatowski, 1999) 
2.2 Health effects of iron deficiency 
The association between iron deficiency anemia and impaired neurocognitive function is 
well established, and is independent of psychosocial and environmental factors. The 
association is especially strong in young children and infants (Oski, 1979). There is evidence 
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that iron deficiency that has not progressed to anemia is also associated with poor 
neurocognitive function (Akman et al., 2004; Cook & Lynch 1986; Grantham-McGregor & 
Ani, 2001; Oski, 1983, 1985; Pollitt et al., 1986). Many possible mechanisms for the 
association have been suggested and investigated, but the true etiology is unknown (Beard, 
2001; Erikson et al., 2001; Ortiz et al., 2004). Whether and to what extent this poor 
neurocognitive function can be reversed by correcting the deficiency is debated (Akman et 
al, 2004; Lozoff et al., 1982, 1996, 2000; Oski, 1983; Walter et al., 1989) 
Many types of anemia such as hemoglobinopathies, hemolytic anemias and iron deficiency 
lead to increased absorption of both iron and lead from the GI tract. Coupled with the 
increased incidence of pica in these anemias, one effect of anemia, including that due to iron 
deficiency, is the increased incidence of lead poisoning and its health effects.  
3. Differential diagnosis of microcytic anemia 
Students are traditional taught that the differential diagnosis of microcytic anemia includes 
five possible conditions: 
1. Iron deficiency anemia 
2. Thalassemia trait 
3. Lead poisoning 
4. Chronic disease 
5. Sideroblastic anemia 
Figure 1 shows a general schema for distinguishing these disorder based on RBC size (MCV) 
and hemoglobin level. The figure is not meant to show the exact values for these disorders, 
but to emphasize the relative values and emphasizes their overlap. After considering some 
of the disorders that overlap with iron deficiency, this chapter will focus on the severe 
anemias that are severely microcytic, i.e. those that are most likely due to iron deficiency. 
Note that lead poisoning is not included in the figure because as explained below it is now 
considered more of a consequence than a cause of iron deficiency; sideroblastic anemia is 
also not seen because it is not a distinct condition and thus shows considerable 
heterogeneity in hemoglobin and MCV. Likewise, bone marrow failure syndromes such as 
Diamond-Blackfan anemia, the erythropoietin deficiency of end stage renal failure, transient 
erythroblastopenia of childhood, and leukemia encompass a wide variety of separate 
disorders with different combinations of MCV and hemoglobin, but none of these are 
microcytic. 
It is important to keep in mind that the presence of one disorder does not exclude others. 
For example, iron deficiency may occur in patients with thalassemia, and patients may have 
concomitant acute and chronic bleeding. Also, the relationship is altered by therapy; hence 
patients who have been partially or inadequately treated may have values that do not fit the 
expected relationships. 
From a practical sense, when considering the above five disorders, the severely microcytic 
anemias limit this differential for the most part to the top two, and further considering only 
those that are severely anemic to a large extent eliminates all but the first. As we shall see, a 
large part of microcytic anemia in children, as in adults, and certainly the severe clinically 
important cases, is due to iron deficiency anemia. As will be discussed, once iron deficiency  
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Fig. 1. Approximate relationship of anemias according to hemoglobin and red cell size 
(MCV) 
is determined to be likely, the cause of the deficiency must be determined, and it is 
important for the clinician to distinguish blood loss from other causes. This list of causes 
varies depending on the age of the patient, the severity of the anemia and the severity of 
microcytosis. The chapter will outline a more thorough differential for all causes, leading 
towards a proper diagnosis before initiating treatment. We will emphasize that iron therapy 
alone is not adequate therapy; as such treatment alone will leave the cause of the anemia 
undiagnosed and untreated. 
3.1 Acute blood loss 
Since iron deficiency anemia is almost always due to chronic blood loss, the distinction 
between acute and chronic blood loss must be made. While both lead to anemia, the causes 
as well as the signs and symptoms are profoundly different between the two. As to the 
cause, acute blood loss can occur externally by any route or internally into practically any 
space, including intracranial, intrathoracic, retroperitoneal and abdominal. Isolated acute 
blood loss is normocytic, with a reticulocyte count that is not elevated until several days 
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after the event, providing the patient survives and has adequate iron stores, i.e. there is not 
coexistent chronic blood loss. Therefore the anemia of acute blood loss is due to blood loss, 
while the anemia of iron deficiency is due to iron loss, and is in fact a bone marrow failure 
syndrome limited to red cells due to lack of substrate (iron). 
Signs and symptoms of acute blood loss are very different from those of chronic blood loss. 
Acute blood loss leads to volume depletion and can rapidly progress to tissue 
hypoperfusion and shock, while the slow onset of anemia that occurs with chronic blood 
loss allows hemodynamic compensation. Children especially can tolerate extremely low 
hemoglobins if gradual in onset, without cardiac decompensation and no end organ effects. 
These children will appear pale, and have compensatory tachycardia, and may have 
dyspnea and headache on exertion, but very small children may have no signs other than 
pallor and mild fussiness. Some children will appear “yellow” due to underlying skin 
pigmentation, especially if the diet includes yellow vegetables, but actual jaundice is easy to 
exclude due to the lack of scleral icterus. 
We will now discuss in some detail the five traditional causes of microcytic anemia, using 
some specific cases to illustrate. 
3.2 Sideroblastic anemia 
The sideroblastic anemias are a heterogeneous group of congenital and acquired bone 
marrow disorders defined by the presence of pathologic iron deposits within the 
mitochondria of erythroid precursors. The anemia may be mild, moderate or severe and 
may be normocytic, microcytic, or macrocytic and is typically characterized by a relative 
reticulocytopenia (Flemming, 2009). There are several known and incompletely 
characterized congenital causes, but all are rare including atransferrinemia, 
hypotranferrinemia (Shamsian et al., 2009), and others (Iolascon et al., 2009). Acquired 
causes include a variety of toxic exposures, drugs, and myelodysplastic syndromes, as well 
as copper deficiency. Many of these, although included in a full discussion of anemia and 
microcytic anemia, do not need to be considered in this chapter because they only rarely 
present as a severe anemia that is severely microcytic. Copper deficiency, for example is 
extremely rare, is usually normocytic, and the major manifestations are neurologic rather 
than hematologic. 
3.3 The anemia of “chronic disease” (Case 1) 
A 10 year old boy was referred to pediatric hematology clinic for anemia occurring on a 
previous blood test. Two months earlier he had been hospitalized briefly for a high fever 
and rash. While in the hospital, a CBC showed a mild microcytic anemia (hgb 10.0 g/dL 
(normal 11.9-15.4 g/dL), MCV 75 fL (normal 80-95 fL). He recovered well and was 
subsequently discharged. He had since been well, with no subsequent fevers, and no weight 
loss or night sweats. He had had no increased fatigue or exercise intolerance. His family 
history was negative for any hematologic disorders or malignancies. He had no chronic 
medical conditions, took no medications, and had no known drug allergies. 
In clinic, he appeared healthy, cooperative and in no distress. His skin showed no rash, 
bruises, jaundice, or pallor. He had no lymphadenopathy, scleral icterus, or conjunctival 
pallor. His lungs were clear with no wheezes, and his heart sounds were normal with no 
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murmur. His abdomen was soft and nontender with no organomegaly, although his liver 
was palpable and slightly tender to palpation, but his spleen was not palpable. His 
extremities were well perfused with no edema. Two months after his original CBC his 
hemoglobin had risen to 11 g/dL (normal 12-15 g/dL), and MCV was 72.9 fL (normal 74-
82). His ferritin was 38 ng/mL (normal 10-200 ng/mL). Iron studies were normal as was his 
hemoglobin electrophoresis and blood smear. 
3.3.1 Discussion 
Typically the anemia of chronic disease, also called the anemia of inflammation, is a mild 
normocytic or mildly microcytic anemia. Usually it is associated with chronic conditions such 
as IBD, and the anemia resolves with effective treatment of the underlying condition. As this 
case illustrates however, the anemia of “chronic“ disease can be associated with 
inflammatory conditions of shorter duration such as chronic strep infections, recurrent otitis 
media, or viral infections. The RDW is often slightly elevated as a result of slight anisocytosis, 
reflecting ineffective iron recycling. The anemia itself is mild and asymptomatic and will not 
respond to iron unless there is concomitant iron deficiency. Since ferritin is an acute phase 
reactant, an elevated level does not imply the patient has adequate iron stores, but a low level 
indicates inadequate stores. Again, this type of anemia is included in a full discussion of 
microcytic anemia in children, but will not be discussed further in this chapter because the 
anemia by itself does not have the features that would or should bring it to the attention of a 
gastroenterologist, i.e. by the severity of the anemia or the microcytosis, although the 
underlying inflammatory condition itself may involve the GI tract. Distinguishing iron 
deficiency from the anemia of inflammation is usually not difficult from the history and CBC, 
but serum transferrin receptor (sTfR) levels, if available, have been shown to help distinguish 
them (Oliveras et al., 2000; Skikne, 1998, Vazquez et al., 2006). 
3.4 Lead poisoning 
The association between lead poisoning and microcytic anemia has long been assumed to be 
a direct inhibition of lead on heme synthesis, leading to a sideroblastic effect. This 
mechanism is supported by the basophilic stippling present and the markedly elevated free 
erythrocyte protoporphyrin values in these patients. More likely, however, the lead 
poisoning is a secondary effect of severe iron deficiency. The mechanism is twofold, in that 
severe iron deficiency increases the incidence of pica (Buchanan, 1999, 2003; Eden, 1999), 
and increases the absorption of lead from the gut. The incidence of Pica may be higher than 
generally assumed (Corbett et al., 2003). The precise pathophysiology of Pica is unknown, 
but is probably related to CNS iron deficiency. Patients often consume laundry starch, ice, 
soil, or clay. Both clay and starch can bind iron in the gastrointestinal tract and exacerbate 
iron deficiency (Crosby, 1982; Gonzalez et al., 1982; Thomas et al., 1976). At any 
concentration of lead, inhibition of ferrochelatase is most marked when the iron 
concentration is lower (Piomelli et al., 1987), but the neurologic effects of lead may be severe 
in the absence of anemia in children. Thus, it is important to address both the lead poisoning 
and the anemia and to find and treat the cause of the bleeding rather than solely addressing 
the lead poisoning. There is evidence that replacing iron in patients with concomitant iron 
deficiency and lead poisoning helps the body eliminate lead (McGeehan, 2003; Rondó et al., 
2006; Wright et al., 2003). 
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3.5 Thalassemia trait (Case 2) 
A 23 month old girl was referred to Pediatric Hematology for investigation of anemia. 
Thalassemia was suspected due to a family history of “Mediterranean anemia.” Her father 
and some of his family members were known to be a carrier for thalassemia. He had been 
treated with high dose iron, but said that it did not help and made him ill. His family was 
originally from Sicily, where he lived for 8 years. She had no siblings. 
The patient had generally been healthy, with normal growth and development, except for a 
brief febrile seizure a few months earlier. Her diet included fruits, vegetables, pasta, and 
lentils. She took no medications. On exam, she appeared healthy and alert. She was engaging 
and playful. She was slightly pale but showed no signs of icterus, petechiae, or ecchymoses. 
She had no adenopathy or splenomegaly. Her heart rate was regular, and her lungs were clear. 
Screening lab work was remarkable for a mild anemia that was severely microcytic with a 
hemoglobin of 11 g/dL (normal 10.5-14 g/dL), MCV 60.2 fL (normal 70-90 fL) a year earlier 
and more recently 9.6 g/dL and 54.9 fL. A hemoglobin electrophoresis was remarkable for 
an elevated hgb A2 of 5.5 percent. Molecular studies had been done and showed that she 
was a carrier of two separate thalassemia mutations. 
3.5.1 Discussion 
This patient is a carrier of beta thalassemia, as is clear from the history as well as lab results. 
The clue is the relatively mild anemia with severe microcytosis. The blood smear in 
thalassemia trait typically has significant target cells present, and usually a hemoglobin 
electrophoresis shows an elevated hemoglobin A2 or F percentage. More quantitative ways 
to distinguish thalassemia trait from iron deficiency include the Mentzer index (Mentzer, 
1973), as well as a variety of other methods of varying degrees of sensitivity and specificity 
(Demir et al. ,2002; Piomelli et al., 1976). The Mentzer index is calculated as the MCV 
divided by the RBC; a value over 13 is somewhat predictive of iron deficiency, while a value 
below 13 is more typical of beta thalassemia trait. Unfortunately in a practical sense, many 
cases fall near the line, especially those that are not clinically obvious one way or the other. 
The RDW is of limited use since it is increased in iron deficiency as well as a variety of 
hemoglobinopathies including thalassemia. 
The presence of thalassemia trait does not exclude iron deficiency, which usually can be 
ruled out with a ferritin level and iron studies. Without iron deficiency, regular iron 
supplementation should not be given; not only will iron not improve the mild anemia, but 
over time could lead to iron overload, particularly because the mild anemia causes increased 
iron absorption form the gut. Thalassemia trait itself requires no therapy or follow-up, but 
genetic counseling should be considered because of the risk of having children with 
thalassemia major. To avoid unnecessary lab evaluations and therapy, the patient and 
family need to have a clear understanding of these points. Iron or folic acid deficiency, 
pregnancy or intercurrent illness may exacerbate the anemia in patients with thalassemia 
trait. The specific clinical phenotype depends on the precise genetic defect in heterozygous 
and especially homozygous individuals. In patients with microcytosis, hypochromia and 
erythrocytosis but without evidence of iron deficiency or elevated hgb A2 and Hgb F levels, 
one of the alpha thalassemia carrier states is likely. These too are benign conditions where 
proper genetic and medical counseling of the patient and family is imperative.  
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4. Iron deficiency 
As is evident above, cases of microcytic anemia that are NOT due to iron deficiency are 
usually easy to distinguish. The remaining cases in this chapter are all due to iron 
deficiency. With two notable exceptions, severely microcytic severe anemias in children are 
due to chronic gastrointestinal blood loss. Figure 2 shows the relative frequencies of the 
major causes of iron deficiency anemia to be explained in the following sections, illustrating 
the 2 major sites of blood loss (gastrointestinal and vaginal) and the two major 
gastrointestinal etiologies (blood loss and iron malabsorption). 
 
Fig. 2. Relative frequencies of causes of iron deficiency anemia (not to scale) 
Because so much of the body’s iron resides in hemoglobin, anemia is one of the first signs of 
iron deficiency, but anemia is actually a late stage of iron depletion. Iron deficiency leading 
to anemia is a continuum, but there are three recognized phases: 
1. Prelatent iron deficiency occurs when tissue stores are depleted, without a change in 
hemoglobin level. The serum ferritin level will be low.  
2. Latent iron deficiency occurs with depletion of iron from the reticuloendothelial system. 
TIBC increases and the serum iron level will fall as newly produced erythrocytes will be 
iron deficient, but the overall hemoglobin level and MCV remain normal. 
3. Iron deficiency anemia occurs when a substantial portion of the erythrocyte population is 
affected, resulting in anemia, microcytosis and hypochromia. 
With adequate treatment, these stages occur in reverse, i.e. the anemia resolves before 
adequate iron stores are replenished. 
Several pediatric cases will be presented and discussed to illustrate the importance of the 
gastrointestinal tract in severe iron deficiency anemia. However, the initial case is of severe 
microcytic anemia occurring in an adult to make the connection between microcytic anemias 
and gastrointestinal blood loss clear. 
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4.1 Severe microcytic anemia in an adult (Case 3) 
A 63 year old male presented to his physician with complaints of fatigue and shortness of 
breath, progressive over several weeks. The physician noted that the patient looked pale and 
ordered a complete blood count. The CBC revealed a hemoglobin of 5.9 g/dL and an MCV 
of 59 fL. The physician correctly interpreted this as a severe microcytic anemia, and that this 
anemia was of relatively recent onset. The physician considered transfusions and a 
prescription for oral iron as therapy for the anemia. However, upon considering the etiology 
of the anemia with the above history, he knows that the microcytosis is not consistent with a 
lesion leading to acute blood loss. Chronic blood loss is the only possibility, and that blood 
loss MUST be gastrointestinal. He referred the man to a gastroenterologist for a thorough 
investigation. 
4.1.1 Discussion 
For this patent, while several more benign lesions leading to chronic blood loss can be 
responsible, the lesion must be found, as colon cancer must be considered highly likely until 
proven otherwise. The sequence of events is therefore clear: The patient has developed a 
lesion in his GI tract that has been losing blood slowly over at least several months. Since the 
blood loss is relatively slow, the patient‘s bone marrow easily makes up for the anemia at 
first, but eventually stores of iron are depleted from his liver and other sites. At that point 
his anemia becomes more severe and begins to be microcytic, until the anemia itself 
becomes severe enough to cause the complaints that lead him to seek help from his 
physician. In retrospect the patient may or may not have noticed the typically black or tarry 
stools, depending on the rate of bleeding, and in fact the stool may not even consistently test 
positive for blood since the bleeding is often intermittent. In fact, testing the stool for blood 
in such a case is not necessary, as there can be no other cause of this type of anemia in this 
man but gastrointestinal bleeding. A negative stool test is in no way reassuring; this man 
must be referred to find the specific lesion. Transfusion and iron therapy do not treat the 
bleeding. It should even be stated that in such a case of anemia the hematologist plays no 
role. At any age the more severe the anemia and the microcytosis, the more likely that blood 
loss rather than a nutritional cause is the responsible mechanism. 
The following pediatric cases will use the same concepts illustrated in the above case to 
emphasize the role of the gastroenterologic system in the etiology and therapy of severe 
microcytic anemias. 
4.2 Milk enteropathy (Case 4) 
A 14 month old boy presented to his pediatrician for a one year well child checkup. At the 
visit however his parents explained to the pediatrician that he had been pale for about the 
last month or so, not feeding well, and had some pica like behaviors. He had recently been 
more fussy and was sleeping poorly. They denied any jaundice, change in bowel or urinary 
habits or breathing difficulties. They denied bloody or black stools. They reported poor 
feeding when offered a variety of foods, and until very recently his diet relied heavily on 
milk, and he would typically go through a gallon every other day. The family lived in an 
older apartment with chipping paint that the parents admitted the child sometimes peeled 
from the walls. His growth and development had otherwise been normal. He took no 
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medications and had no known allergies. He had three healthy half siblings. His mother was 
of German ancestry and had been anemic herself in the past. The father also denied any 
significant family history. 
In clinic, the patient was alert and active but fussy during the exam. He was markedly pale, 
with no jaundice, bruising, petechiae, or rash. His tympanic membranes and oropharynx 
were clear. He had no adenopathy. His lungs were clear with no wheezes, and heart sounds 
were normal with no murmurs. His abdomen was soft and nontender with no 
hepatosplenomegaly. His extremities were well perfused with no edema. 
Blood work was remarkable for a hemoglobin of 4.7 g/dL and MCV of 63 g/dL, a severe 
(and severely microcytic) anemia. His CBC was otherwise unremarkable except for red cell 
morphologic abnormalities consistent with severe iron deficiency. A serum lead level was 
only 4 mcg/dL. 
The patient had a severe microcytic, hypochromic anemia, but was well compensated with 
no sign of heart failure. His parents were instructed to stop his milk entirely and he was 
started on therapeutic iron supplements. They were instructed that concomitant intake of 
orange juice would aid absorption of the iron. Follow-up labs were planned to assure his 
anemia was improving, but the plan was for him to continue taking the iron for several 
months after his anemia resolved, in order to replenish his iron stores. Milk could be added 
back to the diet, but only with meals, as soon as the anemia had begun to improve. 
4.2.1 Discussion 
This child presents with a common cause of iron deficiency anemia in the 1-2 year old. Just 
as in the adult male in the first case above, he has an acquired, severe anemia that is severely 
microcytic, and by far the most likely cause is chronic gastrointestinal blood loss. And like 
the adult, this child requires a GI workup. However, in this case an adequate workup 
consists mostly of the history of excess milk consumption along with the physical exam and 
some simple labs to classify the severity and type of anemia, so no referral to a pediatric 
gastroenterologist is required, and endoscopic procedures are not needed. If the history of 
excessive milk consumption were not present, then such a referral would be required, and 
procedures such as a Meckel’s scan or endoscopy would be needed to find another cause, 
i.e. a specific gastrointestinal lesion. 
Consumption of cow’s milk may contribute to iron deficiency through several mechanisms. 
Whole milk given to young infants under a year of age, especially under 6 months of age, 
leads to iron deficiency anemia (American Academy of Pediatrics, 1992; Chessare, 1988; 
Fomon et al., 1981; Tunnessen & Oski, 1987; Wilson et al., 1964). Cow’s milk and human 
milk both have low iron content, but the bioavailability of iron in human milk is greater. 
(Picciano & Deering, 1980) Cow‘s milk also replaces iron-rich foods in the diet. In addition, 
components in cow’s milk such as calcium and caseinophosphopeptide can directly interfere 
with iron absorption (Ani-Kibangou et al., 2005; Hallberg et al., 1992). For severe anemia, 
these mechanisms can exacerbate the anemia, along with increased demand from the 
neonatal growth spurt, but the major mechanism is direct gastrointestinal bleeding. 
Whole milk protein causes an enteropathy in the immature gut that leads to GI bleeding. 
What is not generally understood however is that these same effects continue into the 
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second year of life for some children, so that excessive whole milk given to some toddlers 
causes an enteropathy with enough chronic blood loss to create severe iron deficiency 
anemia (Buchanan, 1999; Kwiatowski et al., 1999). For these severe anemias the cause is 
often misunderstood to be “nutritional” due to the above mechanisms of poor iron 
bioavailability and absorption. While inadequate iron in the diet might lead to a mild iron 
deficiency, the severe anemia in the case above can only be caused by chronic 
gastrointestinal bleeding. As for the adult, testing for occult blood is not needed. The 
etiology of the blood loss is exposure of the gut to the excessive milk protein. Treatment 
includes iron supplementation, but the enteropathy must be treated as well, by removing 
the excess milk from the diet. Transfusion therapy is usually not needed regardless of how 
low the hemoglobin, unless signs of decompensation such as heart failure are present, and 
in those cases must be done cautiously. A reasonable approach in these severe cases is to 
stop the milk entirely and provide therapeutic iron. After several weeks, when labs indicate 
improvement in the hemoglobin from the therapeutic iron, milk can be restarted, in 
moderate amounts with meals. 
Compliance with iron therapy can be an issue, especially in this age group. Intravenous iron 
can be considered in these cases, or other forms of iron such as heme iron (Proferrin®, 
Colorado Biolabs, Inc.), (Nissenson et al. , 2003) that can be more palatable and well 
absorbed with fewer side effects, but efficacy studies in children are lacking. 
4.3 Crohn’s disease (Case 4) 
A 14-year-old male was seen in pediatric hematology clinic in consultation for anemia. A 
month earlier he had had two episodes of pneumonia and bronchitis that were treated with 
antibiotics. He then started complaining of fatigue, prompting a CBC that revealed 
microcytic anemia that was subsequently shown to be due to iron deficiency. 
The patient reported a long history of diarrhea once or twice a day, associated with bloating 
and cramping, especially after eating but could not relate it to any particular food. He 
denied any history of bloody stools, hematuria, or mucosal bleeding. There was no history 
of fevers, weight loss, cough, or difficulty breathing, and the rest of the review of systems 
was negative. His development had been normal. He had had no previous hospitalizations 
or surgeries. His immunizations were up-to-date. His only current medication was iron 325 
mg PO daily started a week prior. 
The patient had four healthy sisters. His mother had a history of iron deficiency with heavy 
periods but there was no other history of anemia in the family. His paternal grandfather has 
a history of diverticulitis and a cousin of his father had a history of Crohn's disease. 
On exam his weight was 59.5 kg, between the 25th and 50th percentiles for age. His exam 
was mostly normal, with some voluntary guarding but no obvious abdominal tenderness, 
masses or organomegaly. Abdomen was nondistended, soft, nontender, with active bowel 
sounds. His extremities showed full range of motion of all joints, nontender, and well 
perfused, and his neurologic exam was grossly intact.  
His CBC was normal except for a microcytic anemia (hgb 10.2 g/dL, MCV 67.1 fL), and a 
mild thrombocytopenia, all consistent with iron deficiency anemia. Hemoglobin 
electrophoresis was normal and his blood smear was normal. 
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The patient was referred to Pediatric Gastroenterology where endoscopic exam showed 
mild esophagitis, chronic gastritis, a normal duodenum, lymphoid aggregates and a focal 
granuloma in his colon, consistent with Crohn’s disease. Medical treatment was successful 
in alleviating his symptoms and his anemia.  
4.3.1 Discussion 
This boy presented with an acquired moderate anemia that was severely microcytic. As with 
the previous two cases, chronic slow gastrointestinal bleeding is the likely cause, leading to 
iron loss, eventually leading to depletion of stores of iron and the characteristic anemia. A 
full discussion of the pathophysiology and therapy of Crohn’s disease and inflammatory 
bowel disease is beyond the scope of this chapter but the hematologic manifestations are 
likely due to the slow blood loss, although the anemia of inflammation may play a role as 
well. 
4.4 Iron deficiency from gastrointestinal bleeding – Summary 
In all three of these cases, the microcytic anemia was due to slow gastrointestinal blood loss, 
although the specific cause of the blood loss was different, and to a large extent age 
dependent. The approach to the underlying cause is therefore age dependent: 
Toddler   Excessive whole milk ingestion 
   Other causes, e.g. Meckel’s diverticulum 
School age/Teen  Inflammatory bowel disease 
   Menorrhagia 
   Other causes, e.g. AV malformation, ulcer 
Adult   Colon Cancer 
   Other causes, e.g. ulcer 
One common feature of the above cases is that although all presented with a severe 
microcytic anemia, none of the underlying causes were fundamentally hematologic in 
nature. Therefore in the overwhelming majority of cases of microcytic anemia, these patients 
have a gastrointestinal cause (slow gastrointestinal blood loss) and need to be referred to a 
gastroenterologist for diagnosis of the underlying cause. There are two exceptions to the 
above generalizations. One is a special case of non gastrointestinal blood loss, and the other 
is due to a defect in iron absorption, although even that cause is still gastrointestinal. These 
exceptions are illustrated in the two cases below:  
5. Iron deficiency not due to gastrointestinal bleeding 
5.1 Menorrhagia (Case 6) 
A 12-year-old female was referred to pediatric hematology clinic for a possible bleeding 
disorder. She had had heavy menstrual periods since menarche 6 months previously. She 
had been admitted to a local community hospital 4 months earlier at which time she was 
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found to be profoundly anemic with a hemoglobin of 5.9 g/dL, MCV 68.2 fL with symptoms 
of anemia requiring several blood transfusions. She was started on oral birth control pills 
with resolution of her menorrhagia. She was also started on daily iron sulfate tablets. 
Apart from dysfunctional uterine bleeding, the patient did not have a past medical history 
of bleeding problems, nosebleeds, easy bruising, petechiae or mucosal bleeding. She denied 
any loose, bloody, tarry stools or abdominal pain. She had no food allergies. She was 
healthy before the onset of menarche except for daily headaches which had been evaluated 
by CT. Her father said he experienced similar headaches as an adolescent. Her father denied 
a family history of bleeding disorders or menorrhagia. She was doing well in 7th grade and 
enjoyed cheerleading. 
In clinic the patient was alert and in no apparent distress. She was afebrile, with normal vital 
signs. Skin was unremarkable with no petechiae or bruising. Her conjunctivae were pink 
without pallor. Abdomen was soft, nontender, nondistended without hepatosplenomegaly. 
A comprehensive coagulation workup showed no evidence of a systemic bleeding disorder. 
At the time of her visit to pediatric hematology clinic her hemoglobin was 12.5 g/dL, MCV 
82.4, fL, both normal. A ferritin level was normal. 
5.1.1 Discussion 
As demonstrated by the first three cases above, acquired severe microcytic anemias are 
almost always due to chronic gastrointestinal blood (i.e. iron) loss. One notable exception 
is demonstrated in this case, in which the route of bleeding is vaginal. There is a common 
misconception that menstruating females have lower average hemoglobin levels because 
of normal menstrual bleeding. While there is overlap between the normal ranges of males 
and female hemoglobins, the lower average values in females are due to lower 
testosterone levels, not vaginal bleeding. Hence adults have higher hemoglobins than 
children, and males have higher values than females. Normal menstruation can lead to 
iron deficiency but not anemia; therefore actual anemia implies abnormal bleeding. 
Abnormal bleeding can be an acute vaginal hemorrhage from a single or a few heavy 
periods, but it is chronic bleeding from many heavy periods that leads to iron deficiency 
anemia, as in this case. 
As most cases of severe microcytic anemia have a GI cause, a gastroenterologist rather than 
a hematologist should be involved. Dysfunctional uterine bleeding requires a gynecologic 
workup, but a proportion of these cases have an underlying bleeding disorder, so it is these 
cases that should also be referred to a hematologist for an adequate workup for conditions 
such as von Willebrand’s disease and platelet function disorders. Women with menorrhagia, 
especially if present since menarche, have an incidence of von Willebrand’s disease of 
around 13%, considerably higher than the general population incidence of 1% to 2% (Kadir 
et al., 1998; Lukes et. al., 2005). For the most part however, the management involves oral 
contraceptive pills. It should be noted that if there is not a convincing history of several 
heavy periods, a gastrointestinal cause should still be sought. 
Other causes of chronic bleeding and iron loss leading to iron deficiency anemia are rare 
and usually obvious from the history. Iron deficiency and iron deficiency anemia can result 
from pulmonary hemosiderosis and from renal bleeding in Berger’s disease. These rare 
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routes should be considered if the history is not consistent with the more common causes or 
if the patient does not respond adequately to therapy. 
5.2 Celiac disease (Case 7) 
A five year old boy presented to his primary care physician with pallor and was found to 
have a severe microcytic anemia. Stool was negative for occult blood. He was referred to a 
pediatric hematologist who diagnosed iron deficiency anemia. He had occasional 
complaints of abdominal pain but no vomiting, diarrhea or constipation. He had not lost 
any weight but had grown poorly over the past year, falling from the 60th to the 30th 
percentile for weight and the 50th to the 40th for height. He was referred to a pediatric 
gastroenterologist, where further studies were done, including an endoscopy showing 
villous atrophy with increased numbers of intraepithelial lymphocytes consistent with celiac 
disease. He was placed on a gluten free diet. Three months later his hemoglobin was normal 
and his weight had increased to the 50th percentile. 
5.2.1 Discussion 
Although chronic gastrointestinal bleeding is the major cause of severe iron deficiency 
anemia, there are notable exceptions that involve the GI tract, and lead to severe anemia due 
to poor iron absorption alone. The model disorders that fit into this category are celiac 
disease and tropical sprue (Lombardo, 2006). Celiac disease has been shown to be a 
relatively common cause of anemia in adults, and therefore may be underdiagnosed in 
children; it is increasingly recognized as presenting with a spectrum of severity (Van Heel, 
2005). Genetics play a strong role in susceptibility but the full genetic pattern is incompletely 
understood. 
Iron absorption may also be disrupted when substantial segments of bowel, particularly the 
proximal duodenum, are removed surgically. Intractable inflammatory bowel disease, 
traumatic abdominal injury, and structural defects such as intestinal volvulus or 
intussusception, as well as necrotizing enterocolitis and typhlitis may necessitate intestinal 
resection, leading to a defect in iron absorption that may take years to manifest clinically. 
There are also rare gastrointestinal disorders leading to either malabsorption of iron or 
chronic blood loss or both, such as collagenous gastritis (Suskind et al., 2009), epidermolysis 
bullosa (Fridge & Vichinsky, 1998) and short gut syndromes. 
To the general practitioner however, it is enough to remember that unless dysfunctional 
uterine bleeding is elicited from the history, or for any male or prepubertal female, the cause 
of any severe, acquired severely microcytic anemia must be gastrointestinal, which should 
guide the appropriate referral. 
6. Initial workup of suspected anemia in children 
In a child with suspected anemia based on history and exam, a minimal workup should be 
obtained. The goal is to characterize the anemia, and to evaluate the other cell lines 
(platelets, granulocytes) that define bone marrow function. In most cases a CBC with 
differential, reticulocyte count, iron panel, ferritin level, and lead level give a strong 
indication as to the cause and define the therapy. 
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In general, the more cell lines that are depressed, and the lower the values, the more likely is 
an underlying marrow disease. Hence, pancytopenia (neutropenia, anemia, and 
thrombocytopenia) makes leukemia more likely while an isolated single cytopenia 
(neutropenia, anemia, or thrombocytopenia) makes a peripheral disorder outside the 
marrow more likely. If leukemia or a primary marrow failure is suspected, referral to a 
pediatric hematologist/oncologist should be made promptly for further testing, including a 
marrow evaluation. An isolated severe microcytic anemia is not consistent with leukemia 
and indicates slow blood (i.e. iron) loss (gastrointestinal or vaginal), or in the case of celiac 
disease, lack of iron absorption. The severe depletion of iron leads to marrow failure in a 
sense, in that the marrow is unable to complete heme synthesis. Despite the marrow 
“failure,“ further marrow evaluation of marrow function is not part of the evaluation, as the 
underlying cause is entirely outside the marrow. 
In iron deficiency anemia a clue to otherwise normal marrow function is often provided by a 
“left shift” of the other cell lines; leukocytosis, elevated neutrophil count, increased bands and 
other immature forms, and an elevated platelet count with large platelets. The reticulocyte 
count is often only mildly elevated, reflecting the lack of iron substrate. Hemolytic anemias 
such as sickle cell disease, autoimmune hemolytic anemia and hereditary spherocytosis also 
shift cell lines to the left, but are not microcytic and present with a much higher reticulocyte 
count. A high reticulocyte count makes a hemolytic anemia likely, especially if the anemia is 
normocytic or mildly macrocytic. B12 and folate deficiency are not microcytic and are 
considerably rarer than iron deficiency. The iron panel is usually consistent with other studies, 
but serum iron may be misleading, as recent ingestion of iron may elevate the value. Ferritin, 
as an acute phase reactant, may also be elevated in a deficiency state, but low values always 
represent iron deficiency, and occur in no other condition. A lead level should be considered, 
not as a cause of microcytic anemia, but because of its association with iron deficiency due to 
pica and increased lead absorption, especially in small children. 
Children, especially the very young tolerate chronic anemia extremely well. It is not unusual 
for a toddler with a hemoglobin well below five to act perfectly normal, with the very slow 
onset of pallor as the only manifestation of the anemia. Some fussiness and irritability might 
be noticed in retrospect. Often these children appear yellow due to underlying normal 
pigments. True jaundice can be ruled out if the sclerae are white, and lab evaluation of liver 
function is therefore not necessary. Hepatosplenomegaly is unusual, as is true 
decompensation e.g. heart failure, but shortness of breath on exertion and headache are 
common in older children and young adults. 
7. Therapy of iron deficiency anemia 
The therapy of iron deficiency anemia is strongly guided by the cause. Iron therapy is only 
part of the treatment. For mild anemias due to previous iron loss that has resolved, oral iron 
is all that is required. If bleeding is ongoing, iron may partially correct the anemia without 
affecting the underlying cause, leading to delay in diagnosis and therapy of the underlying 
cause. The most egregious example is the adult with colon cancer; Iron therapy alone would 
allow the cancer to progress without diagnosis. 
Transfusions are usually not required, especially in children, but should be considered in 
cases of decompensation or heart failure. It is said that transfusions for chronic anemia in 
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children are given because of the elevated heart rate of the doctor, rather than the patient. If 
used, packed red cells should be given slowly under the direction of a pediatric 
hematologist or other experienced clinician to avoid the risk of fluid overload due to the 
hyperdynamic state of chronic severe anemia. 
Response to therapy depends on the disorder, the severity of the deficiency and compliance, 
not only with the prescribed iron, but in removing the bleeding source. Especially in 
children whose bleeding is due to excess whole milk, the response to oral iron will be slow 
or nonexistent if the milk intake is not severely cut back or eliminated from the diet. Intake 
of acid foods such as orange juice aid iron absorption, and hypochorhydric states, such as 
produced by proton pump inhibitors, has been reported to impair absorption (Sharma et al., 
2004). The amount of iron in typical vitamin supplements (about 10 mg of elemental iron 
daily), while sufficient to prevent deficiency, is well below the 3-6 mg per kg required as 
treatment. If compliant with therapy, the hemoglobin should rise by 1 g/dL or more during 
the first week, along with an increased reticulocyte count, and the hemoglobin should be 
nearly normal by 4-6 weeks. Iron therapy should be continued for several weeks beyond 
normalization of the hemoglobin, as pointed out previously, in order to replenish iron stores 
in the body. 
8. Conclusion 
Iron deficiency anemia is the leading cause of microcytic anemia when both the anemia and 
the microcytosis are severe. Regardless of the age of the patient, gastrointestinal disorders 
are the most frequent causes, and most of these are due to chronic gastrointestinal bleeding. 
The frequency of the specific causes of the bleeding varies with age. In most cases of severe 
microcytic anemia in children, as in adults, referral to a gastroenterologist is appropriate or 
required.  
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Special focus was addressed to microbial aspects in the gut including recent achievements in the
understanding of function of probiotic bacteria, their interaction with gastrointestinal epithelium and usefulness
in the treatment of human disorders. We hope that this book will provide relevant new information useful to
clinicians and basic scientists as well as to medical students, all looking for new advancements in the field of
gastroenterology.
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